Want to see UNH full AI Analyst Report?
UNH Stock Chart & Stats
$396.59
-$3.64(-0.87%)
At close: 4:00 PM EDT
$396.59
-$3.64(-0.87%)
Day’s Range― - ―
52-Week Range$255.97 - $461.62
Previous CloseN/A
Volume851.50K
Average Volume (3M)4.57M
Market Cap
$339.81B
Enterprise Value$457.39B
Total Cash (Recent Filing)$31.47B
Total Debt (Recent Filing)$73.33B
Price to Earnings (P/E)24.2
Beta0.44
Next Earnings
Oct 13, 2026EPS Estimate
4.12Next Dividend Ex-DateN/A
Dividend Yield2.41%
Share Statistics
EPS (TTM)15.55
Shares Outstanding897,594,850
10 Day Avg. Volume4,281,428
30 Day Avg. Volume4,566,364
Financial Highlights & Ratios
PEG Ratio-1.62
Price to Book (P/B)3.19
Price to Sales (P/S)0.67
P/FCF Ratio18.69
Enterprise Value/Market Cap1.35
Enterprise Value/Revenue1.02
Enterprise Value/Gross Profit4.52
Enterprise Value/Ebitda17.75
Forecast
1Y Price Target
$487.22Price Target Upside22.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering21
EPS Forecast (FY)19.95
Revenue Forecast (FY)$446.01B
Bulls Say, Bears Say
Bulls Say
Revenue And Cash GenerationStrong revenue expansion combined with substantial operating and free cash flow gives UnitedHealth the internal funding to support investment, debt management, and shareholder returns. This cash-generative model provides resilience while the company continues scaling across insurance and health services.
Optum Platform StrengthOptum’s broad care-delivery footprint, high pharmacy-client retention, and technology-enabled efficiency gains reinforce a diversified health-services platform. These capabilities can deepen customer relationships, improve care economics, and create durable differentiation beyond traditional insurance.
Balance Sheet And Capital ReturnImproving debt-to-capital and strong cash generation indicate meaningful financial flexibility, while increased repurchases and dividends demonstrate the ability to return capital without abandoning operating investment. This supports balance-sheet resilience and disciplined allocation over the medium term.
Bears Say
Margin CompressionThe sharp decline in net and EBIT margins shows that revenue growth is currently converting into earnings less efficiently than in prior peak years. Persistent cost pressure or an unfavorable mix could limit profit growth and reduce the operating leverage expected from continued scale.
Elevated Commercial Medical CostsMedical costs running above 11% create a structural challenge for pricing, underwriting, and benefit profitability. The pressure is linked to provider coding, higher encounter costs, specialty drugs, and regulatory processes, making margin recovery dependent on repricing and sustained cost-management execution.
Public Program PressureDeclining Medicare Advantage membership can reduce scale and revenue in a major coverage business, while negative Medicaid margins directly pressure profitability. Although rate actions and improved Medicare margins may help, public-program economics remain a material medium-term constraint.
UnitedHealth News
UNH FAQ
What was UnitedHealth’s price range in the past 12 months?
UnitedHealth lowest stock price was $255.97 and its highest was $461.62 in the past 12 months.
What is UnitedHealth’s market cap?
UnitedHealth’s market cap is $339.81B.
When is UnitedHealth’s upcoming earnings report date?
UnitedHealth’s upcoming earnings report date is Oct 13, 2026 which is in 6 days.
How were UnitedHealth’s earnings last quarter?
UnitedHealth released its earnings results on Jul 16, 2026. The company reported $6.38 earnings per share for the quarter, beating the consensus estimate of $4.907 by $1.473.
Is UnitedHealth overvalued?
According to Wall Street analysts UnitedHealth’s price is currently Undervalued.
Does UnitedHealth pay dividends?
UnitedHealth pays a Quarterly dividend of $2.32 which represents an annual dividend yield of 2.41%. See more information on UnitedHealth dividends here
What is UnitedHealth’s EPS estimate?
UnitedHealth’s EPS estimate is 4.12.
How many shares outstanding does UnitedHealth have?
UnitedHealth has 897,594,850 shares outstanding.
What happened to UnitedHealth’s price movement after its last earnings report?
UnitedHealth reported an EPS of $6.38 in its last earnings report, beating expectations of $4.907. Following the earnings report the stock price went up 1.161%.
Which hedge fund is a major shareholder of UnitedHealth?
Currently, no hedge funds are holding shares in UNH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UnitedHealth Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$487.22 (22.85% Upside)
$487.22 (22.85% Upside)
Blogger Sentiment
Bullish
UNH Sentiment 87%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 316.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $660.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.90%
12-Months-Change
Fundamentals
Return on Equity
2.41%
Trailing 12-Months
Asset Growth
0.37%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
UnitedHealth
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
UNH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reflects a broadly positive tone: strong quarter-to-date financial results (notably double-digit EPS growth and raised guidance), solid operational progress across Optum (AI-led efficiency gains, improved care metrics), and meaningful shareholder returns and balance sheet improvement. However, the company faces notable near-term headwinds—elevated commercial medical cost trends, pressured Medicaid margins, Medicare enrollment declines, and some one-time favorable prior-period development—creating areas of ongoing focus and uncertainty. On balance, the positive developments and upgraded outlook outweigh the challenges, but management emphasizes continued urgency and investment to sustain improvement.View all UNH earnings summariesUNH Revenue Breakdown
78.70% Premiums
11.93% Products
8.50% Services
0.88% Investment and other income
UNH Stock 12 Month Forecast
Average Price Target
$487.22
▲(22.85% Upside)
Technical Analysis
Ownership Overview
0.15% Insiders
26.21% Mutual Funds
0.19% Other Institutional Investors
47.31% Public Companies and Individual Investors